These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 26272936)
1. P-Glycoprotein Transport of Neurotoxic Pesticides. Lacher SE; Skagen K; Veit J; Dalton R; Woodahl EL J Pharmacol Exp Ther; 2015 Oct; 355(1):99-107. PubMed ID: 26272936 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein. Bain LJ; McLachlan JB; LeBlanc GA Environ Health Perspect; 1997 Aug; 105(8):812-8. PubMed ID: 9347896 [TBL] [Abstract][Full Text] [Related]
3. In Vitro P-Glycoprotein-Mediated Transport of Tadalafil: A Comparison with Sildenafil. Higashi H; Watanabe N; Tamura R; Taguchi M Biol Pharm Bull; 2017; 40(8):1314-1319. PubMed ID: 28769012 [TBL] [Abstract][Full Text] [Related]
4. Transport of phosphatidylcholine in MDR3-negative epithelial cell lines via drug-induced MDR1 P-glycoprotein. Abulrob AG; Gumbleton M Biochem Biophys Res Commun; 1999 Aug; 262(1):121-6. PubMed ID: 10448079 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluations of the P-glycoprotein-mediated efflux of dibenzoylhydrazines. Miyata K; Nakagawa Y; Kimura Y; Ueda K; Akamatsu M Toxicol Appl Pharmacol; 2016 May; 298():40-7. PubMed ID: 26995013 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the IPEC-J2 MDR1 (iP-gp) cell line as a tool for identification of P-gp substrates. Ozgür B; Saaby L; Langthaler K; Brodin B Eur J Pharm Sci; 2018 Jan; 112():112-121. PubMed ID: 29146563 [TBL] [Abstract][Full Text] [Related]
7. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium. Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701 [TBL] [Abstract][Full Text] [Related]
8. Ixabepilone, a novel microtubule-targeting agent for breast cancer, is a substrate for P-glycoprotein (P-gp/MDR1/ABCB1) but not breast cancer resistance protein (BCRP/ABCG2). Shen H; Lee FY; Gan J J Pharmacol Exp Ther; 2011 May; 337(2):423-32. PubMed ID: 21262849 [TBL] [Abstract][Full Text] [Related]
9. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2. Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576 [TBL] [Abstract][Full Text] [Related]
10. Interaction of structurally diverse pesticides with the human MDR1 gene product P-glycoprotein. Bain LJ; LeBlanc GA Toxicol Appl Pharmacol; 1996 Nov; 141(1):288-98. PubMed ID: 8917702 [TBL] [Abstract][Full Text] [Related]
11. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice. Uchida Y; Ohtsuki S; Kamiie J; Terasaki T J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264 [TBL] [Abstract][Full Text] [Related]
12. Establishment and characterization of the transformants stably-expressing MDR1 derived from various animal species in LLC-PK1. Takeuchi T; Yoshitomi S; Higuchi T; Ikemoto K; Niwa S; Ebihara T; Katoh M; Yokoi T; Asahi S Pharm Res; 2006 Jul; 23(7):1460-72. PubMed ID: 16779700 [TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution. Shaik N; Giri N; Pan G; Elmquist WF Drug Metab Dispos; 2007 Nov; 35(11):2076-85. PubMed ID: 17709369 [TBL] [Abstract][Full Text] [Related]
14. Combined in silico and in vitro approaches to identify P-glycoprotein-inhibiting pesticides. Guéniche N; Lakehal Z; Habauzit D; Bruyère A; Fardel O; Le Hégarat L; Huguet A J Biochem Mol Toxicol; 2024 Jan; 38(1):e23588. PubMed ID: 37985955 [TBL] [Abstract][Full Text] [Related]
15. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers. Tang F; Ouyang H; Yang JZ; Borchardt RT J Pharm Sci; 2004 May; 93(5):1185-94. PubMed ID: 15067695 [TBL] [Abstract][Full Text] [Related]
16. Characterization of efflux transporters involved in distribution and disposition of apixaban. Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458 [TBL] [Abstract][Full Text] [Related]
17. Effect of organophosphate pesticide diazinon on expression and activity of intestinal P-glycoprotein. Lecoeur S; Videmann B; Mazallon M Toxicol Lett; 2006 Mar; 161(3):200-9. PubMed ID: 16221533 [TBL] [Abstract][Full Text] [Related]
18. In vitro substrate identification studies for p-glycoprotein-mediated transport: species difference and predictability of in vivo results. Yamazaki M; Neway WE; Ohe T; Chen I; Rowe JF; Hochman JH; Chiba M; Lin JH J Pharmacol Exp Ther; 2001 Mar; 296(3):723-35. PubMed ID: 11181899 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic interaction of the antiparasitic agents ivermectin and spinosad in dogs. Dunn ST; Hedges L; Sampson KE; Lai Y; Mahabir S; Balogh L; Locuson CW Drug Metab Dispos; 2011 May; 39(5):789-95. PubMed ID: 21321059 [TBL] [Abstract][Full Text] [Related]
20. A new intestinal cell culture model to discriminate the relative contribution of P-gp and BCRP on transport of substrates such as imatinib. Graber-Maier A; Gutmann H; Drewe J Mol Pharm; 2010 Oct; 7(5):1618-28. PubMed ID: 20701289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]